Medical Device News Magazine

XRHealth and HTC Introduce “Flow Health” and “Focus 3 Health” at HIMSS 2022

Both Solutions Provide Portable Virtual Reality Healthcare Solutions for Hospitals, Rehabilitation Centers, and Patients to Use in the Comfort of their Home

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

XRHealth, the gateway to the healthcare metaverse,  and HTC VIVE, the global leader in premium virtual reality (VR),  announced today “Focus 3 Health” and “Flow Health” powered by XRHealth.

The two separate products using HTC VIVE Focus 3 and HTC VIVE Flow are preloaded with the XRHealth virtual reality treatment rooms and other VR health applications, so that hospitals, rehabilitation centers and individual patients can benefit from remote VR telehealth, no matter where they are.

Individual patients can purchase “Flow Health” for $599. The bundle includes the VIVE Flow immersive glasses, preloaded with XRHealth FDA registered medical applications, and includes a screening video call with an XRHealth clinician. Patients can then sign up for VR Telehealth treatment with an XRHealth clinician, covered by their health plan or pay out of pocket for $69-$119 per week, according to the tier they choose.

Hospitals and rehabilitation centers can purchase the “Focus 3 Health” solution for a $1300 one-time fee, which includes the VIVE Focus 3 headset and the preinstalled XRHealth medical platform. The XRHealth medical platform applications are a subscription service of $1000/month. The devices will be sold under the guidelines and regulations of durable medical equipment and will be FSA/HSA eligible.

“XRHealth, together with HTC, are excited to offer the public VR products specifically designed for the healthcare market,” says Eran Orr, Chief Executive Officer of XRHealth. “We believe in creating healthcare solutions that are limitless and provide continuous access and healthcare opportunities to patients around the globe.”

XRHealth’s healthcare VR applications are FDA and CE registered and transport patients to a virtual clinic, where symptoms of stress, anxiety, depression, ADHD, autism, multiple sclerosis, Parkinson’s Disease, and physical and neurological injuries are treated.  When the patient is in the treatment room, comprehensive data can be measured providing the clinician with valuable insights on treatment progress and outcome.

“At HTC, we believe in the power of VR to change lives,” said Amir Khorram, VP of Enterprise Sales, at HTC VIVE. “We are honored to partner with XRHealth on Flow Health and Focus 3 Health – two innovative solutions centered around the power of the VIVE Focus 3 and the lightweight portability of the VIVE Flow, to offer patients and clinicians immersive remote VR telehealth treatments.”

Both products will be available in June. Customers can preorder here, beginning May 1, 2022.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”